Predictors of clinical response to immunotherapy with or without radiotherapy

by Hiniker, Susan M., Maecker, Holden T., Knox, Susan J.
Published 2015

Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment

by Oronsky, Bryan, Oronsky, Neil, Knox, Susan, Fanger, Gary, Scicinski, Jan
Published 2014

Real Time Dynamic Imaging and Current Targeted Therapies in the War on Cancer: A New Paradigm

by Paulmurugan, Ramasamy, Oronsky, Bryan, Brouse, Chad F, Reid, Tony, Knox, Susan, Scicinski, Jan
Published 2013

RRx-001, A novel dinitroazetidine radiosensitizer

by Oronsky, Bryan, Scicinski, Jan, Ning, Shoucheng, Peehl, Donna, Oronsky, Arnold, Cabrales, Pedro, Bednarski, Mark, Knox, Susan
Published 2016

Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity

by Zhao, Hongjuan, Ning, Shoucheng, Scicinski, Jan, Oronsky, Bryan, Knox, Susan J., Peehl, Donna M.
Published 2015

A pilot study of Ipilimumab in patients with stage IV melanoma receiving palliative radiation therapy

by Knox, Susan, Reddy, Sunil, Hiniker, Susan M, Swetter, Susan, Shura, Lei, Maecker, Holden T
Published 2014

The Implications of Hyponitroxia in Cancer

by Oronsky, Bryan, Fanger, Gary R., Oronsky, Neil, Knox, Susan, Scicinski, Jan
Published 2014

NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001☆

by Scicinski, Jan, Oronsky, Bryan, Ning, Shoucheng, Knox, Susan, Peehl, Donna, Kim, Michelle M., Langecker, Peter, Fanger, Gary
Published 2015

Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001

by Ning, Shoucheng, Sekar, Thillai Veerapazham, Scicinski, Jan, Oronsky, Bryan, Peehl, Donna M., Knox, Susan J., Paulmurugan, Ramasamy
Published 2015

29th Annual meeting of the Society for Immunotherapy of Cancer (SITC)

by Hurwitz, Arthur A, Lee, Sylvia, Knox, Susan, Kohrt, Holbrook, Verdeil, Gregory, Romano, Emanuela, Margolin, Kim, Urba, Walter J, Speiser, Daniel E
Published 2015

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial12: A TITE-CRM Phase I/II Clinical Trial

by Kim, Michelle M., Parmar, Hemant, Cao, Yue, Pramanik, Priyanka, Schipper, Matthew, Hayman, James, Junck, Larry, Mammoser, Aaron, Heth, Jason, Carter, Corey A., Oronsky, Arnold, Knox, Susan J., Caroen, Scott, Oronsky, Bryan, Scicinski, Jan, Lawrence, Theodore S., Lao, Christopher D.
Published 2016